Chris Mcnulty work email
- Valid
- Valid
- Valid
- Valid
Chris Mcnulty personal email
Experienced business development and financial executive with experience in the pharmaceutical, biotechnology and medical device industries. Strong background in licensing transactions, mergers and acquisitions, and private and public company finance.
-
Interim CeoRing TherapeuticsBoston, Ma, Us
-
Chief Financial Officer, Head Of Corporate StrategyRing Therapeutics May 2023 - PresentCambridge, Massachusetts, UsLead business development, strategy and finance teams for a company focused on developing genetic medicines based on a novel commensal viral platform.
-
Chief Financial Officer & Head Of Business DevelopmentVbi Vaccines Inc. Aug 2018 - Apr 2023Cambridge, Ma, UsLed finance and business development teams at a Nasdaq-traded biopharmaceutical company (VBIV) focused on developing next generation vaccines to address unmet needs in infectious disease and immuno-oncology. -
Chief Financial OfficerInvivo Therapeutics Mar 2017 - May 2018Cambridge, Ma, UsLed finance group of a Nasdaq-listed public company, as well as business development and corporate communications. Led finance efforts for over $50-million of financing including a confidentially marketed public offering, a registered direct offering, an ATM offering and a funding commitment. Filed two S-1's for a funding commitment and a financing with prefunded warrants. -
Senior Vice President, Business Development And Investor RelationsInvivo Therapeutics Aug 2015 - Mar 2017Cambridge, Ma, UsLed business development and partnering activities as well as corporate communications, including investor relations and public relations. Business development activities included identifying and evaluating partners for InVivo's lead program in acute spinal cord injury as well as identifying and evaluating partners for programs in chronic spinal cord injury involving neural stem cells and gene therapy.
-
Vice President, Business DevelopmentInvivo Therapeutics Nov 2013 - Aug 2015Cambridge, Ma, UsLed business development and partnering activities around a pipeline of biomaterial and neural stem cell product candidates with applications in spinal cord injury, drug delivery, and surgical sealants.
-
Senior Director, Business DevelopmentRepligen Corporation Nov 2011 - Nov 2013Waltham, Ma, UsCo-led out-licensing of rare genetic neurodegenerative disease programs. Led out-licensing of HDACi platform being developed for Friedreich's ataxia and Huntington's disease, which resulted in a deal with Biomarin. Integral member of deal team for outlicensing of Phase 1 spinal muscular atrophy (SMA) program to Pfizer. -
Director Of Business DevelopmentRepligen Corporation Sep 2010 - Nov 2011Waltham, Ma, UsResponsible for in-licensing and out-licensing activities. Led the acquisition of Novozymes Biopharma Sweden AB, which doubled the size of Repligen and transformed the company into a leading player in the bioprocessing space.
-
Director Of Corporate DevelopmentSeventh Sense Biosystems, Inc. Mar 2009 - Apr 2010Responsible for business development and product strategy for a novel diagnostic technology. Authored a funded Gates Grand Challenges Explorations grant application and authored the first round application for another Gates application that led to $3.3M in funding.
-
Associate Director, Alliance ManagementGenzyme Corporation Jun 2008 - Mar 2009Responsible for alliance management around two significant collaborations in the rare genetic disease area with PTC Therapeutics and Isis/Ionis Pharmaceuticals.
-
Associate Director, Business DevelopmentSanofi Genzyme Sep 2006 - Jun 2008Paris, France, FrLed neurology and diabetes business development efforts. Integral member of deal team for significant licensing and research collaborations transactions with Ceregene (gene therapy), PTC Therapeutics and Isis Pharmaceuticals (antisense therapy). -
Summer InternCommons Capital 2005 - 2005Led initial evaluation of Claros Diagnostics that resulted in an investment.
-
Director Of InformaticsTransform Pharmaceuticals Nov 2003 - Sep 2004UsLed a team of 20 people working in the areas of cheminformatics, data mining, software development, automation, and database administration. Transform was sold to Johnson & Johnson in April 2005 for $230-million. -
Discovery Informatics Group LeaderTransform Pharmaceuticals Jul 2000 - Nov 2003UsLed the design and development of patented, cutting-edge informatics tools that were at the core of Transform’s value proposition. These tools enabled Transform’s proprietary high-throughput experimentation systems.
-
EngineerCereon Genomics Feb 1999 - Jun 2000Developed laboratory automation systems and led the analysis of expression profiling experiments.
-
InternHewlett-Packard Laboratories 1995 - 1998Houston, Texas, UsDeveloped patented methods for performing non-invasive glucose measurement.
Chris Mcnulty Skills
Chris Mcnulty Education Details
-
Harvard Business SchoolBusiness -
Massachusetts Institute Of TechnologyElectrical Engineering And Computer Science
-
Massachusetts Institute Of TechnologyElectrical Engineering And Computer Science
Frequently Asked Questions about Chris Mcnulty
What company does Chris Mcnulty work for?
Chris Mcnulty works for Ring Therapeutics
What is Chris Mcnulty's role at the current company?
Chris Mcnulty's current role is Interim CEO.
What is Chris Mcnulty's email address?
Chris Mcnulty's email address is cm****@****nes.com
What is Chris Mcnulty's direct phone number?
Chris Mcnulty's direct phone number is +178185*****
What schools did Chris Mcnulty attend?
Chris Mcnulty attended Harvard Business School, Massachusetts Institute Of Technology, Massachusetts Institute Of Technology.
What skills is Chris Mcnulty known for?
Chris Mcnulty has skills like Biotechnology, Pharmaceutical Industry, Technology Transfer, Life Sciences, Product Management, Mergers And Acquisitions, Lifesciences, Medical Devices, Start Ups, Cross Functional Team Leadership, Commercialization, Strategy.
Who are Chris Mcnulty's colleagues?
Chris Mcnulty's colleagues are Gilad Doron, Ph.d., Jenna A., Venkata Ravi Naga Rajendra B., Tyler Gauthier, Tanisha Garg, Sudhan Dhavle, Madeline Schanen.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial